A detailed history of Arizona State Retirement System transactions in Arvinas, Inc. stock. As of the latest transaction made, Arizona State Retirement System holds 13,793 shares of ARVN stock, worth $310,894. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,793
Previous 13,386 3.04%
Holding current value
$310,894
Previous $356,000 4.78%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$23.66 - $32.73 $9,629 - $13,321
407 Added 3.04%
13,793 $339,000
Q2 2024

Aug 05, 2024

SELL
$24.46 - $40.4 $61,125 - $100,959
-2,499 Reduced 15.73%
13,386 $356,000
Q1 2024

May 07, 2024

BUY
$36.38 - $52.31 $115,542 - $166,136
3,176 Added 24.99%
15,885 $655,000
Q4 2023

Jan 24, 2024

SELL
$14.19 - $42.33 $3,036 - $9,058
-214 Reduced 1.66%
12,709 $523,000
Q3 2023

Nov 06, 2023

BUY
$19.64 - $28.21 $4,026 - $5,783
205 Added 1.61%
12,923 $253,000
Q2 2023

Aug 01, 2023

SELL
$21.73 - $31.43 $8,496 - $12,289
-391 Reduced 2.98%
12,718 $315,000
Q1 2023

Apr 27, 2023

BUY
$26.15 - $37.26 $9,100 - $12,966
348 Added 2.73%
13,109 $358,000
Q4 2022

Feb 07, 2023

BUY
$32.47 - $57.24 $15,585 - $27,475
480 Added 3.91%
12,761 $436,000
Q3 2022

Nov 07, 2022

BUY
$41.87 - $57.99 $4,270 - $5,914
102 Added 0.84%
12,281 $546,000
Q2 2022

Jul 28, 2022

BUY
$36.01 - $74.24 $52,574 - $108,390
1,460 Added 13.62%
12,179 $513,000
Q1 2022

May 04, 2022

BUY
$60.27 - $81.57 $47,492 - $64,277
788 Added 7.93%
10,719 $721,000
Q4 2021

Feb 04, 2022

SELL
$65.85 - $96.21 $5,070 - $7,408
-77 Reduced 0.77%
9,931 $816,000
Q3 2021

Nov 12, 2021

BUY
$73.2 - $107.87 $22,838 - $33,655
312 Added 3.22%
10,008 $822,000
Q2 2021

Aug 02, 2021

BUY
$60.45 - $84.26 $42,133 - $58,729
697 Added 7.75%
9,696 $747,000
Q1 2021

May 06, 2021

BUY
$58.19 - $91.37 $931 - $1,461
16 Added 0.18%
8,999 $595,000
Q4 2020

Jan 28, 2021

BUY
$20.19 - $84.93 $181,366 - $762,926
8,983 New
8,983 $763,000

Others Institutions Holding ARVN

About ARVINAS, INC.


  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $1.2B
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track Arizona State Retirement System Portfolio

Follow Arizona State Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Arizona State Retirement System with notifications on news.